Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo.
Toxoplasma gondii causes substantial morbidity, mortality, and costs for healthcare in the developed and developing world. Current medicines are not well tolerated and cause hypersensitivity reactions. The dihydrotriazine JPC-2067-B (4, 6-diamino-1, 2-dihydro-2, 2-dimethyl-1-(3'(2-chloro-, 4-trifluo...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Public Library of Science (PLoS)
2008-03-01
|
| coleção: | PLoS Neglected Tropical Diseases |
| Acesso em linha: | http://europepmc.org/articles/PMC2254147?pdf=render |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
